The pathogenesis and clinical significance of xanthelasma palpebrarum

https://doi.org/10.1016/S0190-9622(94)70023-0Get rights and content

Xanthelasma palpebrarum is the most common type of xanthoma. On average, only half the patients with xanthelasma palpebrarum are hyperlipidemic. This review is an attempt to elucidate the pathogenesis and clinical significance of xanthelasma palpebrarum, especially its suggested role as a marker for increased risk for atherosclerosis. In hyperlipidemic patients with xanthelasma, the risk for atherosclerosis may be inferred from the associated lipoprotein and apolipoprotein abnormalities. The possible risk for atherosclerosis in normolipidemic patients with xanthelasma is more obscure because of the relative paucity of epidemiologic data and the conflicting results in some of the lipid studies. Several studies, however, showed decreased high-density lipoprotein cholesterol levels and other lipoprotein and apolipoprotein abnormalities that are associated with atherosclerosis. Therefore, on the basis of the present data, determining the plasma lipoprotein and apolipoprotein levels (especially those associated with increased risk for atherosclerosis) in each normolipidemic patient with xanthelasma appears to be justified.

References (56)

  • TW Cooper et al.

    Verruciform xanthoma: occurrence in eroded skin in a patient with recessive dystrophic epidermolysis bullosa

    J Am Acad Dermatol

    (1983)
  • R Van Furth

    Current view on the mononuclear phagocyte system

    Immunobiology

    (1982)
  • M Aviram

    Low-density lipoprotein and scavenger receptor activities are modulated by secretory products derived from cells of the arterial wall

    Metabolism

    (1989)
  • DS Fredrickson

    Plasma lipid abnormalities in cutaneous and subcutaneous xanthoma

  • ML Parkes et al.

    Xanthelasma palpebrarum

    Laryngoscope

    (1984)
  • JF Pedace et al.

    Xanthelasma palpebrarum

    J Am Med Assoc

    (1965)
  • P Segal et al.

    The association of dyslipoproteinemia with corneal arcus and xanthelasma

    Circulation

    (1986)
  • GO Roederer et al.

    Xanthelasma palpebrarum and corneal arcus in octogenarians [Letter]

    N Engl J Med

    (1987)
  • JB Vacca et al.

    Clinical observations regarding xanthelasma

    Ann Intern Med

    (1959)
  • H Montgomery et al.

    Xanthomatosis: correlation of clinical, histopathologic, and chemical studies of cutaneous xanthoma

    Arch Dermatol

    (1938)
  • AC Curtis et al.

    Effect of feeding a lipotropic substance to patients with xanthelasmas

    Arch Dermatol

    (1945)
  • NN Epstein et al.

    Serum lipoproteins and cholesterol metabolism in xanthelasmas

    Arch Dermatol

    (1952)
  • JA Gómez et al.

    Apolipoprotein E phenotypes, lipoprotein composition, and xanthelasmas

    Arch Dermatol

    (1988)
  • MC Bates et al.

    Xanthelasma: clinical indicator of decreased levels of high-density lipoprotein cholesterol

    South Med J

    (1989)
  • WF Lever et al.
  • O Braun-Falco

    Origin, structure, and function of the xanthoma cell

    Nutr Metab

    (1973)
  • HH Wolff et al.

    Die Ultrastruktur des Xanthelasma palpebrarum: eine morphologische und elektronenmikroskopisch-cytochemische Untersuchung

    Arch Klin Exp Dermatol

    (1970)
  • Cited by (121)

    • Xanthelasma Palpebrarum: An Oculoplastic Viewpoint of Optimal Treatment

      2021, Advances in Ophthalmology and Optometry
      Citation Excerpt :

      Factors that take part in lipid oxidation include metal ions and various enzymes secreted from macrophages, fibroblast, and endothelial cells [12]. An additional pathogenic factor for XP is low HDL levels, because HDL is a main player in reverse cholesterol transport, a process in charge of removal of superfluous cholesterol from peripheral tissues [2,12]. This can partially explain the formation of XP in normolipidemic patients with low HDL levels.

    • A Practical Review of the Management of Xanthelasma palpebrarum

      2023, Plastic and Reconstructive Surgery - Global Open
    • A Modern Approach to Dyslipidemia

      2022, Endocrine Reviews
    View all citing articles on Scopus
    1

    From The Guinter Kahn MD Department of Dermatology, Rambam Medical Center, and The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology.

    View full text